Overview

Tailored Smoking Cessation Treatment for LIVE FOR LIFEĀ® Participants

Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to ascertain: 1) the rate of smoking cessation obtained using an adaptive treatment algorithm developed in previous clinical trials, in order to calculate cost-effectiveness of the treatment; 2) the relationship between genotype and response to cigarette smoking cessation treatment.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
Philip Morris USA, Inc.
Treatments:
Bupropion
Nicotine
Varenicline